Skye Bioscience (NASDAQ:SKYE) Earns “Outperform” Rating from William Blair
William Blair restated their outperform rating on shares of Skye Bioscience (NASDAQ:SKYE – Free Report) in a research note published on Tuesday,RTT News reports. Separately, Craig Hallum lowered their price target on Skye Bioscience from $18.00 to $14.00 and set a “buy” rating on the stock in a research note on Friday, March 21st. Six […]
